Latest Ratios: P/E Ratio 4922.2x · EV/EBITDA N/A · ROE 0.0%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $84M | $71M | $129M | $125M | $114M | $165M | $76M | $103M | $171M | $81M | $63M |
| Enterprise Value | $90M | $77M | $132M | $126M | $115M | $157M | $70M | $97M | $166M | $74M | $60M |
| P/E Ratio → | 4922.22 | 4111.11 | 23.89 | 43.00 | 17.85 | 26.05 | — | 19.91 | 25.28 | 23.16 | — |
| P/S Ratio | 1.00 | 0.85 | 1.52 | 1.56 | 1.53 | 2.91 | 1.59 | 1.85 | 3.32 | 2.04 | 1.92 |
| P/B Ratio | 1.11 | 0.93 | 1.72 | 1.77 | 1.69 | 2.50 | 1.27 | 1.73 | 3.06 | 1.56 | 1.34 |
| P/FCF | — | — | 52.42 | 57.37 | — | — | 18.42 | 23.42 | — | 17.32 | 49.40 |
| P/OCF | 34.43 | 29.20 | 21.96 | 22.57 | 99.03 | 56.90 | 15.39 | 18.82 | 280.18 | 14.05 | 30.68 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.92 | 1.55 | 1.58 | 1.55 | 2.78 | 1.47 | 1.74 | 3.24 | 1.88 | 1.81 |
| EV / EBITDA | — | — | 899.82 | — | — | 16.68 | 26.30 | 12.64 | 18.24 | 13.47 | 28.95 |
| EV / EBIT | — | 21.27 | 16.50 | 20.90 | 12.53 | 18.56 | 39.78 | 14.58 | 20.50 | 15.98 | — |
| EV / FCF | — | — | 53.47 | 58.01 | — | — | 17.02 | 22.09 | — | 15.95 | 46.74 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 37.6% | 37.6% | 39.7% | 34.8% | 31.1% | 34.6% | 33.6% | 31.9% | 33.6% | 33.5% | 32.2% |
| Operating Margin | -7.1% | -7.1% | -1.9% | -7.0% | -7.2% | 14.7% | 3.3% | 11.8% | 15.6% | 11.6% | 3.9% |
| Net Profit Margin | 0.0% | 0.0% | 6.4% | 3.6% | 8.5% | 11.1% | -2.8% | 9.3% | 13.0% | 8.6% | -2.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.0% | 0.0% | 7.4% | 4.2% | 9.5% | 10.0% | -2.2% | 9.0% | 12.5% | 6.9% | -1.8% |
| ROA | 0.0% | 0.0% | 5.9% | 3.3% | 7.9% | 8.9% | -2.0% | 8.0% | 11.2% | 6.4% | -1.7% |
| ROIC | -5.6% | -5.6% | -1.6% | -6.0% | -6.3% | 11.1% | 2.2% | 9.4% | 12.4% | 7.8% | 2.2% |
| ROCE | -7.7% | -7.7% | -2.2% | -7.9% | -7.9% | 13.2% | 2.7% | 11.4% | 14.9% | 9.3% | 2.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.17 | 0.17 | 0.10 | 0.10 | 0.10 | 0.01 | 0.01 | — | — | — | — |
| Debt / EBITDA | — | — | 51.46 | — | — | 0.04 | 0.25 | — | — | — | — |
| Net Debt / Equity | — | 0.08 | 0.03 | 0.02 | 0.02 | -0.11 | -0.10 | -0.10 | -0.07 | -0.12 | -0.07 |
| Net Debt / EBITDA | — | — | 17.65 | — | — | -0.77 | -2.16 | -0.76 | -0.46 | -1.15 | -1.65 |
| Debt / FCF | — | — | 1.05 | 0.63 | — | — | -1.40 | -1.33 | — | -1.37 | -2.66 |
| Interest Coverage | 6.05 | 6.05 | 23.48 | 13.10 | 102.69 | 526.84 | 109.51 | 491.71 | 451.89 | 227.87 | -42.15 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.86 | 1.86 | 2.32 | 2.37 | 2.36 | 3.96 | 5.45 | 4.25 | 3.95 | 5.33 | 5.24 |
| Quick Ratio | 1.21 | 1.21 | 1.52 | 1.59 | 1.40 | 2.66 | 3.65 | 2.91 | 2.77 | 3.80 | 3.31 |
| Cash Ratio | 0.30 | 0.30 | 0.28 | 0.32 | 0.31 | 0.90 | 1.96 | 1.20 | 0.97 | 2.07 | 1.41 |
| Asset Turnover | — | 0.82 | 0.90 | 0.89 | 0.86 | 0.76 | 0.72 | 0.83 | 0.81 | 0.70 | 0.64 |
| Inventory Turnover | 3.39 | 3.39 | 3.56 | 3.98 | 3.13 | 3.32 | 2.88 | 3.62 | 3.74 | 3.53 | 2.89 |
| Days Sales Outstanding | — | 86.06 | 89.32 | 87.48 | 81.70 | 88.16 | 72.75 | 80.72 | 87.39 | 74.21 | 79.46 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.8% | 2.1% | 2.0% | 2.1% | 2.3% | 1.1% | 1.6% | 2.1% | 1.1% | — | — |
| Payout Ratio | 8600.7% | 8600.7% | 48.8% | 90.1% | 40.8% | 28.4% | — | 41.9% | 27.1% | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.0% | 0.0% | 4.2% | 2.3% | 5.6% | 3.8% | — | 5.0% | 4.0% | 4.3% | — |
| FCF Yield | — | — | 1.9% | 1.7% | — | — | 5.4% | 4.3% | — | 5.8% | 2.0% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.2% |
| Total Shareholder Yield | 1.8% | 2.1% | 2.0% | 2.1% | 2.3% | 1.1% | 1.6% | 2.1% | 1.1% | 0.2% | 0.2% |
| Shares Outstanding | — | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $9M | $9M | $9M |
Operating margin structural erosion
According to current market data, NTIC trades at a P/S ratio of 0.97, which appears to reflect a significant conglomerate discount when compared to specialty chemical peers like Innospec or Balchem, likely due to the market's struggle to value the company's non-consolidated joint venture income streams.
The extreme P/E ratio of 4772.22 is largely a function of depressed earnings rather than a premium growth expectation, suggesting that investors are currently ignoring the underlying cash-generative potential of the ZERUST segment. This valuation gap warrants further investigation into whether the market is mispricing the company as a struggling micro-cap rather than a global leader in corrosion prevention.
Based on reported financial figures, NTIC's ROIC has deteriorated from a positive 2.8% in 2024Q4 to a negative 1.5% in 2026Q2, indicating that the company is currently failing to generate returns that exceed its cost of capital during this period of aggressive investment in bioplastics.
The decline in ROIC appears driven by the persistent operating losses in the Natur-Tec segment, which are dragging down the consolidated return profile. Investors should monitor whether management can improve capital allocation efficiency, as the current trend suggests that recent investments are not yet yielding the expected competitive advantages or margin expansion.
As reported in recent quarterly filings, NTIC's cash conversion cycle has expanded to 127 days in 2026Q2, reflecting a persistent inefficiency in managing inventory and receivables that significantly hampers the company's ability to convert sales into immediate liquidity for the parent entity.
The elevated DIO of 104 days suggests that the company may be holding excessive inventory, potentially in anticipation of supply chain volatility or as a result of slower-than-expected product turnover in the Natur-Tec segment. This inefficiency, combined with a DSO of 81 days, indicates that the company lacks the leverage to accelerate cash inflows from its customer base.
As indicated by the company's unique structure, the consolidated operating margin is a frequently misapplied metric that obscures the true earning power of NTIC, as it excludes the highly profitable, non-consolidated joint venture income that serves as the primary engine of the firm's economic value.
Analysts focusing solely on GAAP operating margins may incorrectly conclude that the business is structurally unprofitable, failing to account for the royalty-like cash flows generated by the global ZERUST network. A more accurate assessment would involve adjusting for the equity in income of joint ventures to better reflect the company's actual market share and profitability.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NTIC stock.
Northern Technologies International Corporation's current P/E ratio is 4922.2x. The historical average is 19.9x. This places it at the 100th percentile of its historical range.
Northern Technologies International Corporation's return on equity (ROE) is 0.0%. The historical average is 10.1%.
Based on historical data, Northern Technologies International Corporation is trading at a P/E of 4922.2x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Northern Technologies International Corporation's current dividend yield is 1.77% with a payout ratio of 8600.7%.
Northern Technologies International Corporation has 37.6% gross margin and -7.1% operating margin.